+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Postherpetic Neuralgia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • ID: 4754759
  • Clinical Trials
  • February 2019
  • Region: Global
  • 50 pages
  • VPA Research
1 of 2
The ongoing clinical trial research report- “2019 Postherpetic Neuralgia Ongoing Clinical Trials Study” analyzes the current scenario of all active Postherpetic Neuralgia trials across the world. The report presents top level analysis of global Postherpetic Neuralgia clinical trials across countries, companies and universities. It is designed to provide clear understanding into the Postherpetic Neuralgia trials landscape to assist users for effective long term strategy formulation to beat competition.

The report covers a key snapshot of ongoing trial count, average enrollment per trial across countries.

It also segments the Postherpetic Neuralgia clinical trials by
  • Region (Asia Pacific, Europe, Middle East Africa and Americas)
  • Countries
  • Trial Phase
  • Current Trial Status (Recruiting, Active, Planned, Active but Completed Recruiting, Not Yet Recruiting etc)
  • Type of the trial (Interventional, Observational)
  • Sponsor Type (Companies, Universities, Government Bodies etc)
  • Enrollment across types, sponsor types, geographies, current status and phases
The report also identifies the potential drug candidates under development for treatment of Postherpetic Neuralgia on the basis of intervention type ongoing Postherpetic Neuralgia trials.

The research work is prepared through extensive and continuous research on Postherpetic Neuralgia trials from over 150 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major ongoing trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Postherpetic Neuralgia patients are identified
  • The report includes panorama of ongoing Postherpetic Neuralgia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Postherpetic Neuralgia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 2
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Postherpetic Neuralgia Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
2.2.1 Ongoing Postherpetic Neuralgia Clinical Trials by Region
2.2.2 Average Enrollment of Postherpetic Neuralgia Clinical Trials
2.2.3 Companies participating in Ongoing Trials
2.2.4 Drugs under Study for Postherpetic Neuralgia Treatment, 2019

3. Region wise Postherpetic Neuralgia Clinical Trials
3.1 Asia Pacific Postherpetic Neuralgia Clinical Trials by Country
3.2 Europe Postherpetic Neuralgia Clinical Trials by Country
3.3 North America Postherpetic Neuralgia Clinical Trials by Country
3.4 Middle East and Africa Postherpetic Neuralgia Clinical Trials by Country
3.5 South and Central America Postherpetic Neuralgia Clinical Trials by Country

4. Postherpetic Neuralgia Clinical Trial Trends
4.1 Start Year wise Ongoing Postherpetic Neuralgia Clinical Trials
4.2 Phase wise Ongoing Postherpetic Neuralgia Clinical Trials
4.3 Trial Status wise Ongoing Postherpetic Neuralgia Clinical Trials
4.4 Trial Type wise Ongoing Postherpetic Neuralgia Clinical Trials

5. Postherpetic Neuralgia Average Enrollment Trends
5.1 Average Enrollment in Postherpetic Neuralgia Trials by Year
5.2 Average Enrollment in Postherpetic Neuralgia Trials by Phase
5.3 Average Enrollment in Postherpetic Neuralgia Trials by Status
5.4 Average Enrollment in Postherpetic Neuralgia Trials by Type of Trial

6. Companies Participating in Ongoing Postherpetic Neuralgia Clinical Trials
6.1 Ongoing Postherpetic Neuralgia Trials by Sponsor Type
6.2 Postherpetic Neuralgia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots - Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ongoing Postherpetic Neuralgia Trials - Phase 1
7.2 Ongoing Postherpetic Neuralgia Trials - Phase 2
7.3 Ongoing Postherpetic Neuralgia Trials - Phase 3
7.4 Ongoing Postherpetic Neuralgia Trials - Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Postherpetic Neuralgia Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Ongoing Postherpetic Neuralgia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Ongoing Postherpetic Neuralgia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Ongoing Postherpetic Neuralgia Clinical Trials and Enrolment
Figure 7: North America - Country wise Ongoing Postherpetic Neuralgia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Ongoing Postherpetic Neuralgia Clinical Trials and Enrolment
Figure 9: Postherpetic Neuralgia Ongoing Clinical Trials by Phase
Figure 10: Postherpetic Neuralgia Ongoing Clinical Trials by Trial Status
Figure 11: Postherpetic Neuralgia Ongoing Clinical Trials by Type
Figure 12: Postherpetic Neuralgia Ongoing Clinical Trials by Sponsor Type
Figure 13: Postherpetic Neuralgia Ongoing Clinical Trials by Leading Sponsors
Figure 14: Postherpetic Neuralgia Average Enrollment by Phase
Figure 15: Postherpetic Neuralgia Average Enrollment by Trial Status
Figure 16: Postherpetic Neuralgia Average Enrollment by Type
Figure 17: Postherpetic Neuralgia - Average Enrolment by Type of Sponsors
Figure 18: Postherpetic Neuralgia - Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Postherpetic Neuralgia Ongoing Clinical Trials Snapshot - 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Ongoing Postherpetic Neuralgia Clinical Trials and Enrolment
Table 5: Europe - Country wise Ongoing Postherpetic Neuralgia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Ongoing Postherpetic Neuralgia Clinical Trials and Enrolment
Table 7: North America - Country wise Ongoing Postherpetic Neuralgia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Ongoing Postherpetic Neuralgia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Postherpetic Neuralgia Average Enrollment by Phase
Table 15: Postherpetic Neuralgia Average Enrollment by Trial Status
Table 16: Postherpetic Neuralgia Average Enrollment by Type
Table 17: Postherpetic Neuralgia - Average Enrolment by Type of Sponsors
Table 18: Postherpetic Neuralgia - Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll